PersonFounderExecutive
Evan Sussman
Evan Sussman is the co-founder and CEO of Granata Bio, a Boston-based biopharma company expanding access to fertility care by in-licensing IVF medications proven abroad and bringing them through U.S. clinical development and commercialization. A former fertility business unit head at EMD Serono, he built Granata to be revenue-positive early through a fee-for-service model, then raised a $14M Series A led by GV (Google Ventures), extended it, acquired ovarian-aging biotech Oviva Therapeutics, and struck a strategic investment and co-development deal with Gedeon Richter.
evan sussmangranata biofertilityivfwomens healthreproductive health